SESSION 5: HOW TO COMBINE IMMUNOTHERAPY WITH STANDARD OF CARE
Keynote lecture: Checkpoint inhibition in the radical setting for H&N SCC
neo-adjuvant immunotherapy in HNSCC
Radiation with immunotherapy
Kevin Harrington, United Kingdom
Therapeutic vaccines in HPV+ disease
Christophe Le Tourneau, France
Proferred papers related to session 5
Moderator: Vincent Grégoire, Belgium
SESSION 6: HOW WILL WE TREAT OUR PATIENTS NON-SURGICALLY IN 2030?
Chair: Jesper Grau-Eriksen & Jean-Pascal Machiels
Modern day adaptive RT.
Treatment adaptation for HPV positive disease.
Pernille Lassen, Denmark
Systemic therapy: immune checkpoint inhibitors, still cisplatin, …
Sylvie Rottey, Belgium
Proferred papers related to session 6
Chair: Igor Reshetov
Lunch / virtual booth visit
SESSION 7: QUALITY OF CARE IN TREATMENT OF HEAD AND NECK CANCER AND SURVIVORSHIP
Chair: Andreas Dietz, Germany & Moderator: G. Succo, Italy
How to improve Quality of Care in Surgical Oncology.
René Leemans, The Netherlands
What really matters is the radiation oncologist behind the machine
Vincent Grégoire, Belgium
Optimizing the prescription doses and tolerability of systemic therapy
Thorsten Fureder, Austria
Health related quality of life from diagnosis up to 2 years after treatment: evidence from NET-QUBIC
Irma Verdonck-de Leeuw, The Netherlands
Value based health care.
Yolande Lievens, Belgium
Proferred papers related to session 7
SESSION 8: THYROID CANCER
Surveillance vs. treatment of papillary thyroid cancer
New treatment options in iodine-refractory thyroid cancer
Laura Locati, Italy
Proferred papers related to session 8
Moderator: Ricard Simo